Yüklüyor......
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
OBJECTIVES: Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have demonstrated survival improvements in multiple advanced cancers, but also cause immune-related adverse events (IRAEs). IRAEs wit...
Kaydedildi:
| Yayımlandı: | Ann Rheum Dis |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5333990/ https://ncbi.nlm.nih.gov/pubmed/27307501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2016-209595 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|